C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
12/2002
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492368 Benzamidine derivatives as factor XA inhibitors
12/05/2002	WO2002096900A1 Novel magenta colorants for use within ink systems
12/05/2002	WO2002096899A1 Synthesis of cannabinoids
12/05/2002	WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	WO2002096846A1 Uncatalysed addition reactions
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002074036A3 Substituted benzopyranones as telomerase inhibitors
12/05/2002	WO2002011707A3 Drugs for incontinence
12/05/2002	US20020183558 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183318 Novel derivatives of flavones, xanthones and coumarins
12/05/2002	US20020182535 Resolution, sensitivity and smoothness on side surfaces of a transferred pattern; photolithography
12/05/2002	CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	EP1100769B1 Aminomethylcarboxylic acid derivatives
12/04/2002	EP1045841B1 Novel genipin derivative having liver protection activity
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002	CN1383426A Obesity inhibitory materials
12/04/2002	CN1383381A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives
12/04/2002	CN1383380A 干细胞增强材料 Stem Cell Reinforcements
12/04/2002	CN1382689A Process for extracting natural tocopherol
12/04/2002	CN1382688A Chromone compounds with antineoplastic activity and its open-loop products and preparing process
12/04/2002	CN1095468C Method of separating and refining soybean isoflavone from soybean dregs
12/04/2002	CN1095467C Process of extracting total flavone from grape seeds
12/04/2002	CN1095466C Soya total flavone, its prepn. method and medical use thereof
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	CA2216617C New flavone derivatives, their preparation procedures and the pharmaceutical compositions containing them
12/03/2002	CA2052365C Substituted cyclopentenyl-oxabicyclooctanes, cyclopentenyl-formylcyclohexenes, cyclopentenyl-hydroxymethyl cyclohexenes and camphonyl spirocyclooxaoctane-containing compositions, organoleptic uses thereof and process for preparing same
11/2002
11/28/2002	WO2002094836A2 Methods for preparation and use of psorospermin analogs
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	US20020177619 Steroid sulphatase inhibitors
11/28/2002	CA2489768A1 Methods for preparation and use of psorospermin analogs
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/27/2002	EP1260510A1 Fluorescent probes for the quantitation of zinc
11/27/2002	EP1260509A1 Uses of tocopherol esters
11/27/2002	EP1260508A1 Reagents for the quantitation of active oxygen
11/27/2002	EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002	EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/27/2002	EP1112264B1 Polyalkoxylated naphthopyrans
11/27/2002	EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002	CN1382134A Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/27/2002	CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002	CN1382042A Treatment of emphysema using RAR selective retinoid agonists
11/27/2002	CN1381451A Process for extracting flavone from green-peel pomelo
11/27/2002	CN1094936C New flavnoe compounds, process for preparing them and pharmaceutical compositions containing them
11/27/2002	CN1094935C Method for extracting natural VE from sunflowers seed oil
11/26/2002	US6486343 Substituted phenyl keto enols as pesticides and herbicides
11/26/2002	US6486325 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
11/26/2002	US6486164 Used for treatment of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, parkinson-like motor disorders and motion disorders neuroleptic agents.
11/21/2002	WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002	WO2002092111A1 Use of extracts and preparations from iris plants and tectorigenin as medicaments
11/21/2002	WO2002092076A1 Substituted coumarins and quinolines as caspases activators
11/21/2002	WO2002076381A3 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
11/21/2002	WO2002070507A3 Glycorticoid receptor antagonists for treatment of diabetes
11/21/2002	US20020173667 Use in photochromic articles such as lenses; 2H-naphtho(1,2-b)pyran structure characterized by having an aromatic substituent in the 5 position
11/21/2002	US20020172793 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer
11/21/2002	DE10123503A1 Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia
11/20/2002	EP1258491A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2002	EP1258252A1 Integrin expression inhibitors
11/20/2002	EP1258200A2 Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof
11/20/2002	EP1257537A1 Therapeutic morpholino-substituted compounds
11/20/2002	EP1027346B1 Photochromic derivatives of carbocyclically fused naphthopyrans
11/20/2002	EP0984952B1 A new salt
11/20/2002	CN1380882A C10 ester substituted taxanes as antitumor agents
11/20/2002	CN1380291A Method for separating and recovering epoxycyclohexane from cyclohexane oxidation by-product light oil
11/19/2002	US6482961 Reacting trimethylhydroquinone with isophytol or phytol in the presence of a bis(perfluorinated hydrocarbyl sulphonyl)imide catalyst or a metal salt thereof in organic solvent; recovering (all-rac)- alpha -tocopherol
11/19/2002	US6482943 Quinones as disease therapies
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/19/2002	CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/19/2002	CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/14/2002	WO2002090342A1 Chromene compound
11/14/2002	WO2002090319A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
11/14/2002	WO2002089781A2 Methods of treating hyperlipidemia
11/14/2002	WO2002076970A3 Tocopherol succinate derivatives and compositions
11/14/2002	WO2002062324A3 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/14/2002	WO2002055014A3 Therapeutic chroman compounds
11/14/2002	WO2002055013A3 Therapeutic chromone compounds
11/14/2002	WO2002055012A3 Therapeutic heterocyclic compounds
11/14/2002	WO2001020995A9 Compounds directed against pilus biogenesis and activity in pathogenic bacteria; methods and compositions for synthesis thereof
11/14/2002	US20020169315 Spirofluorenopyrans for ophthalmic applications
11/14/2002	US20020169135 Administration of a G1 and/or S phase drug, which is preferably beta-lapachone, or a derivative or analog thereof, combined with a G2/M phase drug such as a taxane derivative, which is advantageously paclitaxel
11/14/2002	US20020168433 Plant extracts; mixture of isoflavones, lignan, saponin, catechin and benzoic acid
11/14/2002	DE10122898A1 Use of 2-phenyl-4-chromanone derivatives to mask bitter or metallic tastes in foods, consumables and oral pharmaceutical products
11/14/2002	CA2445504A1 Methods of treating hyperlipidemia
11/13/2002	EP1256350A1 New toralactone and its derivation and the use of decreasing blood-fat and losing weight
11/13/2002	EP0833631B1 Robustaflavone and derivatives thereof as antiviral agents
11/13/2002	CN1379769A Novel composition and method or stabilizing same
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379027A Process for extracting pure catechin from tea
11/13/2002	CN1379026A Process for preparing gingko leaf extract
11/12/2002	US6479671 Process for producing optically active chromene derivative
11/12/2002	US6479670 Selective retinoid acid receptor agonists
11/12/2002	US6479539 Procyanidin compositions and methods for making the same
11/12/2002	US6479497 Compounds having a selective effect at a subgroup of 5-hydroxytryptamine receptors, designated the h5-ht1b receptor
11/12/2002	US6479081 Sulphite water (h2o+so2) is used as solvent for extraction; raw tannin fraction is purified by selectively adsorbing the tannin polyphenol compounds on resin and by subsequent filtering.

1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 242